Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Paclitaxel Plus SC Pertuzumab/Trastuzumab for Neoadjuvant HER2+ Breast Cancer
NCT07848633Phase 2Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2026
- Primary completion
- Dec 2029
01
Overview
A Phase 2 trial of paclitaxel oral solution in breast cancer, sponsored by Jiangsu Provincial People's Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
paclitaxel oral solution
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07848633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07848633.